SC 13G: UroGen Pharma Ltd.

AI Summary

SC 13G filing by UroGen Pharma Ltd..

Risk Assessment

Risk Level: low

Filing Documents

• p24-2248sc13g.htm (SC 13G) — 66KB
• p24-2248exhibit99.htm (EX-99) — 5KB
• 0000902664-24-004451.txt ( ) — 73KB

(a)

Item 1(a). Name of Issuer. UroGen Pharma Ltd. (the " Issuer ").

(b)

Item 1(b). Address of Issuer's Principal Executive Offices. 400 Alexander Park Drive, 4 th Floor, Princeton, New Jersey, 08540.

(a)

Item 2(a). Name of Person Filing. This statement is filed by: (i) Point72 Asset Management, L.P. (" Point72 Asset Management ") with respect to ordinary shares, par value NIS 0.01 per share (" Ordinary Shares "), of the Issuer held by Point72 Associates, LLC, an investment fund it manages (" Point72 Associates "); (ii) Point72 Capital Advisors, Inc. (" Point72 Capital Advisors Inc .") with respect to Ordinary Shares held by Point72 Associates; and (iii) Steven A. Cohen (" Mr. Cohen ") with respect to Ordinary Shares beneficially owned by Point72 Asset Management and Point72 Capital Advisors Inc. Cubist Systematic Strategies, LLC, an advisor under common control with Point72 Asset Management, acts as a sub-advisor with respect to a portion of the Ordinary Shares reported herein . Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 99.1 , pursuant to which they have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act.

(b)

Item 2(b). Address of Principal Business Office. The address of the principal business office of Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen is 72 Cummings Point Road, Stamford, CT 06902.

(c)

Item 2(c). Place of Organization. Point72 Asset Management is a Delaware limited partnership. Point72 Capital Advisors Inc. is a Delaware corporation. Mr. Cohen is a United States citizen.

(d)

Item 2(d). Title of Class of Securities. Ordinary Shares, par value NIS 0.01 per share.

(e)

Item 2(e). CUSIP Number. M96088105 Item 3. If this Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the Person Filing is a: Not applicable. CUSIP No. M96088105 13G Page 6 of 7 Pages Item 4. Ownership. The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each Reporting Person. Such information is as of the close of business on June 21, 2024. Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen own directly no Ordinary Shares. Pursuant to an investment management agreement, Point72 Asset Management maintains investment and voting power with respect to the securities held by Point72 Associates. Point72 Capital Advisors Inc. is the general partner of Point72 Asset Management. Mr. Cohen controls each of Point72 Asset Management and Point72 Capital Advisors Inc. The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the Ordinary Shares reported herein. Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ]. Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Point72 Associates has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5 percent of the outstanding Ordinary Shares. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable. Item 8. Identification and Classification of Members of the Group. Not appl